Skip to main content
. 2021 May 10;26(9):2806. doi: 10.3390/molecules26092806

Table 2.

Predicted ADMET descriptors for the tested isoflavonoids and remdesivir.

Compound BBB Level a Absorption Level b PPB c Solubility Level d
1 3 0 2 3
2 2 0 2 3
3 3 0 1 3
4 2 0 0 3
5 2 0 2 3
6 1 0 0 2
7 2 0 0 2
8 2 0 1 3
9 2 0 2 3
10 1 0 2 2
11 2 0 0 2
12 4 2 0 4
13 3 0 1 3
14 3 0 2 3
15 3 0 2 3
16 3 0 1 3
17 3 0 1 3
18 3 0 2 3
19 2 0 2 2
20 2 0 1 2
21 3 0 1 3
22 3 0 1 3
23 2 0 2 2
24 3 0 2 3
25 3 0 2 3
26 2 0 2 3
27 1 0 2 2
28 4 1 2 2
29 4 1 2 1
30 4 1 2 2
31 4 1 2 2
32 2 0 0 2
33 4 1 1 2
34 4 1 0 2
35 4 1 0 2
36 4 0 1 3
37 4 2 2 2
38 4 0 0 2
39 3 0 1 3
40 3 0 1 3
41 3 0 2 3
42 3 0 2 3
43 3 0 0 3
44 3 0 2 3
45 4 0 2 3
46 4 0 0 3
47 3 0 0 3
48 2 0 1 2
49 4 0 2 2
50 4 0 1 2
51 2 0 1 2
52 2 0 2 2
53 4 2 2 1
54 4 2 2 1
55 2 0 1 2
56 4 2 2 2
57 4 1 2 1
58 4 1 1 2
59 2 2 2
Remdesivir 4 3 0 2

a BBB level, blood brain barrier level, 0 = very high, 1 = high, 2 = medium, 3 = low, 4 = very low. b Absorption level, 0 = good, 1 = moderate, 2 = poor, 3 = very poor. c PBB, plasma protein binding, 0 means less than 90%, 1 means more than 90%, 2 means more than 95%. d solubility level, 0 = extremely low, 1 = very low, 2 = low, 3 = good, 4 = optimal.